White Paper

Agile Process Development In Biopharmaceuticals

Source: IDBS
Agile Process Development In Biopharmaceuticals

The development of novel therapeutic products involves a complex network of internal departments and external partners. Different groups across Process Development organizations typically use a variety of approaches to capture, manage, analyze and report data.

These can range from paper and Excel, to in-house developed electronic systems or commercial solutions. Regardless of their IT maturity, the lack of a consistent approach has a negative impact on the agility of the business including:

  • Process scientists are unable to identify issues in a timely manner, resulting in a reactive approach to problems
  • Reports take time to compile and are out of date as soon as they are created
  • Critical decisions are made based on incomplete information

This whitepaper describes the business benefits Process Development teams can expect to achieve and by taking a platform approach.